Clinical Trial Update: An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an all-oral combination of capecitabine and cyclophosphamide in metastatic breast cancer; sponsor is Fudan University, with registry st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN